Lilly CEO Predicts Better Patent Protection Will Unleash Scientific Innovation Across China
This article was originally published in The Pink Sheet Daily
Executive Summary
In Shanghai, Lechleiter says he believes China is poised to make a significant contribution to medical innovation.
You may also be interested in...
Global Spread Of Technologies, West’s Economic Downturn And East’s Rise Will Fundamentally Change Pharma Giants By 2020
BEIJING - A number of coinciding trends - ranging from the worldwide spread of technologies that can link up scientists and research models from Boston to Beijing to the decline of productivity at traditional drug R&D labs to the rise of the Eastern economic powers - will fundamentally change the structure of the West's pharmaceutical giants and their development of new molecules
Hutchison MediPharma and Eli Lilly Sign New Discovery Deal
BEIJING - Shanghai-headquartered Hutchison MediPharma signed a new partnership agreement with Eli Lilly on drug discovery and development, according to MediPharma's chief executive officer
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.